ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

IPSC Century Therapeutics Inc

2.88
-0.27 (-8.57%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Century Therapeutics Inc IPSC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.27 -8.57% 2.88 16:25:51
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.22 2.82 3.25 2.88 3.15
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/4/202406:00GLOBECentury Therapeutics to Present at Chardan’s 8th Annual..
11/4/202406:00GLOBECentury Therapeutics Strengthens Position in Autoimmune..
08/4/202415:05GLOBECentury Therapeutics Presents New Preclinical Data..
25/3/202406:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
19/3/202406:00GLOBECentury Therapeutics to Present at the H.C. Wainwright 2nd..
14/3/202406:30GLOBECentury Therapeutics Reports Full Year 2023 Financial..
08/3/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:40EDGAR2Form 144 - Report of proposed sale of securities
06/3/202415:19EDGAR2Form 144 - Report of proposed sale of securities
05/3/202417:03GLOBECentury Therapeutics Announces Six Upcoming Poster..
21/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202412:04EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16/2/202415:18EDGAR2Form 144 - Report of proposed sale of securities
07/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:25EDGAR2Form 144 - Report of proposed sale of securities
05/2/202414:23EDGAR2Form 144 - Report of proposed sale of securities
01/2/202406:00GLOBECentury Therapeutics to Present at the Guggenheim Healthcare..
19/1/202416:03EDGAR2Form 8-K - Current report
11/12/202309:30EDGAR2Form 8-K - Current report
09/12/202311:00GLOBECentury Therapeutics Presents Initial Data from CNTY-101..
06/12/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/12/202306:46EDGAR2Form 8-K - Current report
06/12/202306:30GLOBECentury Therapeutics Receives FDA Clearance of IND..
21/11/202306:00GLOBECentury Therapeutics to Present at the Piper Sandler 35th..
09/11/202306:56EDGAR2Form 8-K - Current report
09/11/202306:01GLOBECentury Therapeutics Reports Third Quarter 2023 Financial..
09/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:00GLOBECentury Therapeutics and FUJIFILM Cellular Dynamics Announce..
03/11/202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202308:00GLOBECentury Therapeutics to Present Initial Clinical Data..
03/10/202307:00EDGAR2Form 8-K - Current report
26/9/202306:00GLOBECentury Therapeutics to Present at the Chardan 7th Annual..
09/8/202306:40EDGAR2Form 8-K - Current report
09/8/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:30GLOBECentury Therapeutics Reports Second Quarter 2023 Financial..
29/6/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202315:05EDGAR2Form 8-K - Current report
11/5/202306:30GLOBECentury Therapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock